As more patients receive pacemakers, implantable cardioverter defibrillators (ICDs), and cardiac resynchronization therapy systems, Cardiac Device Surveillance has become a cornerstone of long-term cardiovascular care. This session focuses on how structured in-clinic and remote follow-up can detect lead malfunctions, battery depletion, programming issues, arrhythmias, and early signs of infection before they result in clinical deterioration. Participants will explore how device data—ranging from stored electrograms and arrhythmia counters to thoracic impedance and activity logs—can be used to optimize therapy and guide timely interventions. The session is designed for cardiologists, electrophysiologists, device nurses, and technologists who manage growing device populations across diverse practice settings.

Clinicians around the world increasingly search for a cardiology conference as remote monitoring platforms, connectivity standards, and alert workflows rapidly evolve. This session reviews best practices for enrolling patients in remote monitoring, configuring alerts to minimize noise while capturing critical events, and integrating reports into electronic health records. Attendees will learn how proactive surveillance can shorten time to clinical decision-making in response to arrhythmias, lead alerts, or device parameter changes. Real case examples will illustrate how early detection of lead fracture, inappropriate shocks, rising thresholds, or fluid overload trends can prevent hospitalizations and improve quality of life.

A major emphasis is on developing robust CIED follow-up programs (cardiac implantable electronic device follow-up) that combine technology with clear processes and roles. Participants will examine workflow models for device clinics, including triage of incoming alerts, division of responsibilities between clinicians and device specialists, and documentation standards that support billing, compliance, and quality reporting. The session also explores patient-facing aspects such as education on transmitter use, expectations around contact and follow-up, and strategies for engaging patients who have limited digital literacy or connectivity.

Future developments, including fully cloud-based ecosystems, AI-assisted alert prioritization, and integration with broader remote cardiac monitoring, will also be discussed. By the end, attendees will have a practical roadmap for designing or refining device surveillance services that are efficient, scalable, and patient-centered, ensuring the full benefits of device therapy are realized over the long term.